Possible implication of the effector CD4+ T-cell subpopulation TH17 in the pathogenesis of systemic scleroderma

被引:44
作者
Deleuran, Bent [1 ]
Abraham, David J.
机构
[1] Aarhus Univ Hosp, Dept Rheumatol, DK-8000 Aarhus, Denmark
[2] UCL Royal Free & Univ Coll, Sch Med, Ctr Rheumatol, London, England
来源
NATURE CLINICAL PRACTICE RHEUMATOLOGY | 2007年 / 3卷 / 12期
关键词
D O I
10.1038/ncprheum0618
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:682 / 683
页数:2
相关论文
共 12 条
[1]   Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3 [J].
Chen, WJ ;
Jin, WW ;
Hardegen, N ;
Lei, KJ ;
Li, L ;
Marinos, N ;
McGrady, G ;
Wahl, SM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (12) :1875-1886
[2]   Expression and regulation of IL-22 in the IL-17-producing CD4+T lymphocytes [J].
Chung, Yeonseok ;
Yang, Xuexian ;
Chang, Seon Hee ;
Ma, Li ;
Tian, Qiang ;
Dong, Chen .
CELL RESEARCH, 2006, 16 (11) :902-907
[3]   Mechanisms and consequences of fibrosis in systemic sclerosis [J].
Denton, CP ;
Black, CM ;
Abraham, DJ .
NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2006, 2 (03) :134-144
[4]   The IL-6R α chain controls lung CD4+CD25+ Treg development and function during allergic airway inflammation in vivo [J].
Doganci, A ;
Eigenbrod, T ;
Krug, N ;
De Sanctis, GT ;
Hausding, M ;
Erpenbeck, VJ ;
Haddad, EB ;
Schmitt, E ;
Bopp, T ;
Kallen, KJ ;
Herz, U ;
Schmitt, S ;
Luft, C ;
Hecht, O ;
Hohlfeld, JM ;
Ito, H ;
Nishimoto, N ;
Yoshizaki, K ;
Kishimoto, T ;
Rose-John, S ;
Renz, H ;
Neurath, MF ;
Galle, PR ;
Finotto, S .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (02) :313-325
[5]   Control of regulatory T cell development by the transcription factor Foxp3 [J].
Hori, S ;
Nomura, T ;
Sakaguchi, S .
SCIENCE, 2003, 299 (5609) :1057-1061
[6]  
Kurasawa K, 2000, ARTHRITIS RHEUM-US, V43, P2455, DOI 10.1002/1529-0131(200011)43:11<2455::AID-ANR12>3.0.CO
[7]  
2-K
[8]   Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides [J].
Liang, Spencer C. ;
Tan, Xiang-Yang ;
Luxenberg, Deborah P. ;
Karim, Riyez ;
Dunussi-Joannopoulos, Kyriaki ;
Collins, Mary ;
Fouser, Lynette A. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2006, 203 (10) :2271-2279
[9]   Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate [J].
Maini, R. N. ;
Taylor, P. C. ;
Szechinski, J. ;
Pavelka, K. ;
Broell, J. ;
Balint, G. ;
Emery, P. ;
Raemen, F. ;
Petersen, J. ;
Smolen, J. ;
Thomson, D. ;
Kishimoto, T. .
ARTHRITIS AND RHEUMATISM, 2006, 54 (09) :2817-2829
[10]   Is systemic sclerosis an antigen-driven T cell disease? [J].
Sakkas, LI ;
Platsoucas, CD .
ARTHRITIS AND RHEUMATISM, 2004, 50 (06) :1721-1733